Industry Educational Session - Sponsored and promoted by Novartis: Personalised Care in Myelofibrosis - Sponsored by Novartis.
Tracks
-
| Monday, April 20, 2026 |
| 1:35 PM - 2:20 PM |
| Room 4, Upper Level |
Details
This promotional symposia is organised and funded by Novartis Pharmaceuticals UK, Ltd. intended for UK healthcare professionals only. Prescribing Information will be available at the meetings for all Novartis brands mentioned. The speakers have been offered an honorarium for their involvement in this programme.
Relevant Prescribing Information and Adverse Event Statement will be available at the meeting
Join Prof. Adam Mead and Dr. Nauman Butt for an interactive, case‑based 45‑minute session that prioritises the patient experience. By reviewing real UK clinical cases, we will explore how to maximise symptom control and support the restoration of daily function. The discussion will cover key nuances of the Myelofibrosis pathway, including how to optimise ongoing treatment approaches and re‑evaluate therapy for eligible patients who present unique clinical challenges.
UK | FA-11601505 | March 2026
Speaker
Prof. Adam Mead
Professor Of Haematology
University of Oxford
Speaker One
Professor of Haematology at the University of Oxford
Dr Nauman Butt
Consultant Haematologist
Clatterbridge Cancer Centre
Speaker Two
Consultant Haematologist at The Clatterbridge Cancer Centre
